Cellipont Bioservices and WuGen Join Forces for CAR-T Therapies
Cellipont Bioservices, a cell therapy Contract Development and Manufacturing Organization (CDMO), and WuGen, Inc., a clinical-stage biotechnology company, have announced the signing of an agreement…